Gossamer Bio GOSS
NASDAQ GOSS
$0.15 -0.01 (-5.08%)
As of: Aug 21, 2026 · 10:19 AM EDT

Gossamer Bio (GOSS) Net Margin (2024 - 2026)

Gossamer Bio (GOSS) posted quarterly Net Margin of 295.38% for Q1 2026, up 10165.0% year-over-year from N/an in Q1 2025, and up 13.71% quarter-over-quarter from 342.33% in Q4 2025.

Gossamer Bio (GOSS) Net Margin (2024 - 2026) Analysis & Trends

Gossamer Bio's Net Margin history runs 3 years deep, the most recent figure standing at 295.38% for Q1 2026.

  • In Q1 2026, Net Margin rose 10165.0% year-over-year to 295.38%; the TTM figure through Mar 2026 stood at 330.98% (down 27743.0% YoY), while the FY2025 annual figure was 351.49%, down 28916.0% from the prior year.
  • Net Margin for Q1 2026 stood at 295.38%, up from 342.33% in the prior quarter.
  • The five-year high for Net Margin was 225.89% in Q4 2024, with the low at 397.03% in Q1 2025.
  • The 3-year median for Net Margin is 329.2% (2024), against an average of 222.32%.
  • The sharpest annual moves came in 2025 and 2026: Net Margin plunged 56821 bps in 2025, then surged 10165 bps in 2026.
  • Gossamer Bio's Net Margin stood at 225.89% in 2024, then plunged by 252 bps to 342.33% in 2025, then rose by 14 bps to 295.38% in 2026.
  • Business Quant data shows GOSS's Net Margin at 295.38% in Q1 2026, 342.33% in Q4 2025, and 362.73% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 140.22 Bn 132.37 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 86.29 Bn 78.30 Bn 3.93 Bn 30.23%
3 Argenx Se 65.17 Bn 59.98 Bn 1.37 Bn 31.16%
4 Moderna 61.38 Bn 56.24 Bn 52.00 Mn -539.31%
5 BeOne Medicines 42.18 Bn 37.09 Bn 1.53 Bn 13.90%
6 Alnylam Pharmaceuticals 30.99 Bn 27.68 Bn 992.69 Mn 12.74%
7 BioNTech SE 28.45 Bn 10.05 Bn 668.28 Mn -16.51%
8 Insmed 27.47 Bn 26.31 Bn 358.27 Mn -3.12%
9 Royalty Pharma 27.27 Bn 26.43 Bn - 12.09%
10 Gossamer Bio 47.81 Mn -9.22 Mn - -308.63%

Historic Data

Download Data
DateValue
Jun 30, 2026 -331.08%
Mar 31, 2026 -295.38%
Dec 31, 2025 -342.33%
Sep 30, 2025 -362.73%
Jun 30, 2025 -333.13%
Mar 31, 2025 -397.03%
Dec 31, 2024 225.89%
Sep 30, 2024 -325.26%
Jun 30, 2024 51.40%